This Article
Right arrow Full Text (PDF)
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dahlin, D. C.
Right arrow Articles by Henderson, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dahlin, D. C.
Right arrow Articles by Henderson, E. D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?
Journal of Bone and Joint Surgery, 1956;38:1025-1125.
© 1956 by The Journal of Bone and Joint Surgery, Inc

Chondrosarcoma, A Surgical and Pathological Problem

Review of 212 Cases

David C. Dahlin M.D.1 and Edward D. Henderson M.D.2

1 Section of Surgical Pathology, Mayo Clinic and Mayo Foundation
2 Section of Orthopaedic Surgery, Mayo Clinic and Mayo Foundation

1. Chondrosarcoma is a neoplasm of slow growth that usually kills by local enlargement but that may metastasize through the blood stream or the lymphatic system. It is important to differentiate it from the non-malignant chondromatous variants.

2. Microscopic examination of biopsy material permits prediction of malignant course.

3. Local control of the tumor by adequate surgical treatment is the chief problem in therapy. Recurrence of the tumor in the proximal part of the extremity or in the trunk represents an irrevocable failure of treatment in most cases.

4. The ease with which chondrosarcoma implants locally in surgical wounds, including biopsy wounds, constitutes a major problem in management.

5. Conclusions as to the results of treatment of chondrosarcoma that are based on follow-up periods of less than ten years after the last surgical treatment are invalid.

6. Osteogenic sarcoma with a prominent chondroid component should not be grouped with chondrosarcoma.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 JBJSHome page
the Skeletal Lesions Interobserver Correlation amo
Reliability of Histopathologic and Radiologic Grading of Cartilaginous Neoplasms in Long Bones
J. Bone Joint Surg. Am., October 1, 2007; 89(10): 2113 - 2123.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
M. E. Pring, K. L. Weber, K. K. Unni, and F. H. Sim
Chondrosarcoma of the Pelvis : A Review of Sixty-four Cases
J. Bone Joint Surg. Am., November 1, 2001; 83(11): 1630 - 1642.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
P. G. GABOS and J. R. BOWEN
Epiphyseal-Metaphyseal Enchondromatosis. A New Clinical Entity
J. Bone Joint Surg. Am., June 1, 1998; 80(6): 782 - 92.
[Abstract] [Full Text]